Bacitracin
Walgreen Company
Human Otc Drug
NDC 0363-0075Bacitracin is a human otc drug labeled by 'Walgreen Company'. National Drug Code (NDC) number for Bacitracin is 0363-0075. This drug is available in dosage form of Ointment. The names of the active, medicinal ingredients in Bacitracin drug includes Bacitracin - 500 [USP'U]/g . The currest status of Bacitracin drug is Active.
Drug Information:
| Drug NDC: | 0363-0075 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Bacitracin |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Bacitracin |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Walgreen Company |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Ointment |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | BACITRACIN - 500 [USP'U]/g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 24 Oct, 2016 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 16 Jan, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part333B |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Walgreen Company
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 1648110
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| NUI: | N0000008479
|
| Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT). |
| UNII: | 58H6RWO52I
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
| Pharmacologic Class PE: | Decreased Cell Wall Synthesis & Repair [PE]
|
| Physiologic effect or pharmacodynamic effect—tissue, organ, or organ system level functional activity—of the drug’s established pharmacologic class. Takes the form of the effect, followed by `[PE]` (such as `Increased Diuresis [PE]` or `Decreased Cytokine Activity [PE]`. |
| Pharmacologic Class: | Decreased Cell Wall Synthesis & Repair [PE]
|
| These are the reported pharmacological class categories corresponding to the SubstanceNames listed above. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 0363-0075-64 | 1 TUBE in 1 CARTON (0363-0075-64) / 28 g in 1 TUBE | 24 Oct, 2016 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose first aid antibiotic
Product Elements:
Bacitracin bacitracin bacitracin bacitracin light mineral oil petrolatum
Indications and Usage:
Use first aid to help prevent infection in: minor cuts scrapes burns
Warnings:
Warnings for external use only. do not use if you are allergic to any of the ingredients in the eyes over large areas of the body longer than 1 week unless directed by doctor ask a doctor before use if you have deep or puncture wounds animal bites serious burns stop use and ask a doctor if condition persists or gets worse rash or other allergic reaction develops keep out of reach of children. if swallowed, get medical help or contact a poison control center right away: 800-222-1222.
Do Not Use:
Warnings for external use only. do not use if you are allergic to any of the ingredients in the eyes over large areas of the body longer than 1 week unless directed by doctor ask a doctor before use if you have deep or puncture wounds animal bites serious burns stop use and ask a doctor if condition persists or gets worse rash or other allergic reaction develops keep out of reach of children. if swallowed, get medical help or contact a poison control center right away: 800-222-1222.
Dosage and Administration:
Directions adults and children 2 years old and older: clean affected area apply a small amount (an amount equal to the surface area of a finger tip) on the area 1 to 3 times daily may be covered with a sterile bandage children under 2 years old: ask a doctor
Stop Use:
Stop use and ask a doctor if condition persists or gets worse rash or other allergic reaction develops
Package Label Principal Display Panel:
Principal display panel - 28 g tube carton ndc 0363-0075-64 walgreens walgreens pharmacist recommended bacitracin ointment bacitracin, usp first aid antibiotic ointment helps prevent infection in minor cuts, scrapes & burns net wt 1 oz (28 g) principal display panel - 28 g tube carton
Further Questions:
Questions or comments? 866-323-0107